SBIJI Innovation Mar 17, 20211 minChemomab Completes Merger with Anchiano TherapeuticsShares of Chemomab Therapeutics to commence trading on the Nasdaq Capital Market on March 17, 2021 under the new ticker symbol "CMMB"...
SBIJI Innovation Feb 21, 20211 minAyala Pharmaceuticals Announces $25 Million Strategic FinancingFunding Extends Cash Runway through Multiple Expected Value Drivers Into 2023 Funds Expected to Support the Recently Announced...
SBIJI Innovation Feb 11, 20211 minAdicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common StockAdicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement... Read More
SBIJI Innovation Feb 2, 20211 minBiomX Announces Positive Results of a Phase 1a Pharmacokinetic Study for Inflammatory Bowel Disease- BX002 demonstrated safety and tolerability with successful delivery of a high concentration of viable phage to the lower...
SBIJI Innovation Jan 29, 20211 minAyala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with...